Digital medicine is essential for improving healthcare and addressing issues related to access and equity. In the latest episode, learn about the importance of digital medicine, the challenges and opportunities in the industry and the importance of an integrated evidence plan. Plus, CEO and Co-Founder of the Digital Medicine Society (DiMe), Jennifer Goldsack, shares her thoughts on generative AI and advice for young professionals in healthcare.As part of DiMe’s upcoming Integrated Evidence Plans for Digital Health Products (IEP) project, leaders in digital health product development, regulation, reimbursement and commercial strategy will partner with payers, purchasers, policymakers, clinicians and patient groups to identify core components of an integrated evidence plan. If you would like to engage in this project and help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients, learn more and share your interest to join (https://dimesociety.org/access-resources/evidence-defined/#iep-form).

Did you know that there are more than 100 types of liver diseases that affect 1.5 billion people worldwide? Join us as we explore the importance of collaboration and innovation in addressing liver health issues, the role of digital health and equity, and the future of liver health with Donna Cryer, J.D., Founder, President and CEO of the Global Liver Institute. Get the inside scoop on the latest developments in the field of liver health and how they can improve patient outcomes and access to care.

Space exploration and research are rapidly advancing, and life sciences is a key component of this progress. Learn more about the opportunities and developments in space R&D and manufacturing, particularly in the life sciences sector, from Maureen Haverty, VP of Investment at Seraphim Space/Generation Space. 

In this episode with Biotricity CEO and Founder Waqaas Al-Siddiq, PhD, discover how AI is transforming healthcare and how Biotricity's Bioheart device is helping to manage and prevent cardiac conditions.

Communication is a critical skill for leaders and company culture. In this episode, Real Chemistry Founder and Chairman Jim Weiss is joined by Sally Susman, Chief Corporate Affairs Officer of Pfizer and author of "Breaking Through," who shares her insights on the importance of communication in leadership, building corporate and product brands, and navigating challenging conversations. 

7wire Ventures Co-Founder & Managing Partner, Lee Shapiro, discusses how technology and collaboration can revolutionize healthcare to deliver personalized care. Topics include advancing personalized care, collaboration at South by Southwest, leveraging data for personalized healthcare, and the importance of unity and wishes.

Sameer Grover, CNS Sr. Specialty Division Manager at AbbVie, and Romain Bogaerts, Director of AI Product Management at Real Chemistry, discuss the impact of generative AI on creative jobs in the healthcare space. They explore the potential of generative AI in the pharmaceutical industry, highlighting limitations and challenges. They also discuss enhancing processes with generative AI, elevating sales rep performance with data and AI, and the importance of finding a technology-driven partner.

Recorded live from SXSW 2023, Alison Woo, Head of Strategy, Planning and Paid Campaigns, Communications & Government Affairs at GSK, shares what a day in her life looks like, what she gathered at SXSW this year and what it means to be disruptive at a company without being too disruptive.

This presentation, originally recorded in front of a live audience at SXSW 2023, showcases key stories and perspectives on what a day in the life of a leader at Bristol-Myers Squibb looks like. From their experiences and challenges to how their focus on patients drives them to continue to strive in their role during these truly complicated times.Panelists: Dr. Rosanna Ricafort, Vice President, Cell Therapy Clinical Development, Bristol-Myers Squibb Bryant Powell, Associate Director & Chief of Staff, Bristol-Myers Squibb (Co-moderator) Aaron Strout, Chief Marketing Officer, Real Chemistry (Co-moderator)

This panel, originally recorded in front of a live audience at SXSW 2023, discusses innovative data sources for clinical trial recruitment and how to maximize their effectiveness. The panel explores a range of innovative data sources, such as online platforms, real world data and social networks, and how they can be used to find the right candidates for a study. The panelists discuss the advantages and disadvantages of different data sources, such as the potential cost savings, access to a larger pool of potential participants and the ability to target specific populations. They also discuss potential ethical considerations, such as protecting participant privacy and ensuring that the data used is accurate and up-to-date.Panelists Bryan Hansen, Director of Data Science & Digital Health Neuroscience, Johnson & Johnson Maimah Karmo, CEO & President, Tigerlily Foundation Joan Severson, Chief Innovation Officer, Clinical Ink Aaron Strout, Chief Marketing Officer, Real Chemistry (Host)